Skip to main content

3 Result(s)

within Michael Gillette Remove this filter

and

  1. No Access

    Article

    Antiplatelet Management for Coronary Heart Disease: Advances and Challenges

    Coronary heart disease (CHD) remains the leading cause of death in the USA. CHD accounts for 48 % of all cardiovascular mortality or approximately one of every seven deaths. Disruption of atherosclerotic plaqu...

    Michael Gillette, Kathleen Morneau, Vu Hoang… in Current Atherosclerosis Reports (2016)

  2. Article

    Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare

    Beginning in July of 2018, the FDA issued a voluntary recall regarding the presence of a contaminant found in the manufacturing of valsartan. What would ensue has become a largely unprecedented sequence of ala...

    Michael Gillette, Addison Taylor, Djenita Butulija… in Cardiovascular Drugs and Therapy (2020)

    Download PDF (243 KB) View Article

  3. Article

    Open Access

    LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma

    Long interspersed element 1 (LINE-1) open reading frame 1 protein (ORF1p) expression is a common feature of many cancer types, including high-grade serous ovarian carcinoma (HGSOC). Here, we report that ORF1p ...

    Sho Sato, Michael Gillette, Pamela R. de Santiago, Eric Kuhn… in Scientific Reports (2023)

    Download PDF (2149 KB) View Article